These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6630172

  • 41. In vitro translation of type A Clostridium botulinum neurotoxin heavy chain and analysis of its binding to rat synaptosomes.
    Li L, Singh BR.
    J Protein Chem; 1999 Jan; 18(1):89-95. PubMed ID: 10071933
    [Abstract] [Full Text] [Related]

  • 42. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y, Kimura Y, Hiroi T, Sakaguchi G, Kozaki S.
    Biochim Biophys Acta; 1993 Feb 13; 1156(2):213-8. PubMed ID: 8427878
    [Abstract] [Full Text] [Related]

  • 43. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
    Li L, Singh BR.
    J Nat Toxins; 1998 Oct 13; 7(3):215-26. PubMed ID: 9783260
    [Abstract] [Full Text] [Related]

  • 44. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord.
    Habermann E.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Oct 13; 281(1):47-56. PubMed ID: 4273827
    [No Abstract] [Full Text] [Related]

  • 45. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV, Aoki KR, Atassi MZ.
    Infect Immun; 2015 Apr 13; 83(4):1465-76. PubMed ID: 25624352
    [Abstract] [Full Text] [Related]

  • 46. Interaction between Clostridium botulinum neurotoxin and gangliosides.
    Kitamura M, Iwamori M, Nagai Y.
    Biochim Biophys Acta; 1980 Mar 20; 628(3):328-35. PubMed ID: 6768400
    [Abstract] [Full Text] [Related]

  • 47. Binding of sea anemone toxin to receptor sites associated with gating system of sodium channel in synaptic nerve endings in vitro.
    Vincent JP, Balerna M, Barhanin J, Fosset M, Lazdunski M.
    Proc Natl Acad Sci U S A; 1980 Mar 20; 77(3):1646-50. PubMed ID: 6103536
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes.
    Nishiki T, Ogasawara J, Kamata Y, Kozaki S.
    Biochim Biophys Acta; 1993 Nov 28; 1158(3):333-8. PubMed ID: 8251534
    [Abstract] [Full Text] [Related]

  • 53. Binding of Clostridium botulinum neurotoxin to gangliosides.
    Ochanda JO, Syuto B, Ohishi I, Naiki M, Kubo S.
    J Biochem; 1986 Jul 28; 100(1):27-33. PubMed ID: 3759936
    [Abstract] [Full Text] [Related]

  • 54. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
    Kozaki S, Onimaru J, Kamata Y, Sakaguchi G.
    Infect Immun; 1991 Jan 28; 59(1):457-9. PubMed ID: 1987060
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Noxiustoxin and leiurutoxin III, two homologous peptide toxins with binding properties to synaptosomal membrane K+ channels.
    Valdivia HH, Martin BM, Escobar L, Possani LD.
    Biochem Int; 1992 Sep 28; 27(6):953-62. PubMed ID: 1280139
    [Abstract] [Full Text] [Related]

  • 57. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.
    Nagahama M, Sakurai J.
    Infect Immun; 1992 Mar 28; 60(3):1237-40. PubMed ID: 1541539
    [Abstract] [Full Text] [Related]

  • 58. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK, Singh BR.
    Biochemistry; 2004 Apr 27; 43(16):4791-8. PubMed ID: 15096048
    [Abstract] [Full Text] [Related]

  • 59. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin.
    Evans ER, Skipper PJ, Shone CC.
    J Appl Microbiol; 2009 Oct 27; 107(4):1384-91. PubMed ID: 19426271
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.